Literature DB >> 10585851

Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.

S P Cousin1, S R Hügl, M G Myers, M F White, A Reifel-Miller, C J Rhodes.   

Abstract

Mitogenic signal-transduction pathways have not been well defined in pancreatic beta-cells. In the glucose-sensitive rat beta-cell line, INS-1, glucose (6-18 mM) increased INS-1 cell proliferation (>20-fold at 15 mM glucose). Rat growth hormone (rGH) also induced INS-1 cell proliferation, but this was glucose-dependent in the physiologically relevant concentration range (6-18 mM glucose). The combination of rGH (10 nM) and glucose (15 mM) was synergistic, maximally increasing INS-1 cell proliferation by >50-fold. Moreover, glucose-dependent rGH-induced INS-1 cell proliferation was increased further by addition of insulin-like growth factor 1 (IGF-1; 10 nM) to >90-fold at 12 mM glucose. Glucose metabolism and phosphatidylinositol-3'-kinase (PI3'K) activation were necessary for both glucose- and rGH-stimulated INS-1 cell proliferation. Glucose (>3 mM) independently increased tyrosine-phosphorylation-mediated recruitment of growth-factor-bound protein 2 (Grb2)/murine sons of sevenless-1 protein (mSOS) and PI3'K to insulin receptor substrate (IRS)-1 and IRS-2, as well as SH2-containing protein (Shc) association with Grb2/mSOS and downstream activation of mitogen-activated protein kinase and 70 kDa S6 kinase. Glucose-induced IRS- and Shc-mediated signal transduction was enhanced further by the addition of IGF-1, but not rGH. In contrast, rGH was able to activate Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) signal transduction at glucose concentrations above 3 mM, but neither glucose independently, nor glucose with added IGF-1, were able to activate the JAK2/STAT5 signalling pathway. Thus rGH-mediated proliferation of beta-cells is directly via the JAK2/STAT5 pathway without engaging the Shc or IRS signal-transduction pathways, although activation of PI3'K may play an important permissive role in the glucose-dependent aspect of rGH-induced beta-cell mitogensis. The additive effect of rGH and IGF-1 on glucose-dependent beta-cell proliferation is therefore reflective of rGH and IGF-1 activating distinctly different mitogenic signalling pathways in beta-cells with minimal crosstalk between them.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585851      PMCID: PMC1220686     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms.

Authors:  A Sjöholm
Journal:  Diabetes       Date:  1997-07       Impact factor: 9.461

2.  Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene.

Authors:  E D Galsgaard; F Gouilleux; B Groner; P Serup; J H Nielsen; N Billestrup
Journal:  Mol Endocrinol       Date:  1996-06

Review 3.  The IRS-signalling system during insulin and cytokine action.

Authors:  L Yenush; M F White
Journal:  Bioessays       Date:  1997-06       Impact factor: 4.345

Review 4.  Oncoprotein networks.

Authors:  T Hunter
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.

Authors:  J C Chow; P R Ling; Z Qu; L Laviola; A Ciccarone; B R Bistrian; R J Smith
Journal:  Endocrinology       Date:  1996-07       Impact factor: 4.736

6.  Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion.

Authors:  S Khoo; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

7.  Disruption of IRS-2 causes type 2 diabetes in mice.

Authors:  D J Withers; J S Gutierrez; H Towery; D J Burks; J M Ren; S Previs; Y Zhang; D Bernal; S Pons; G I Shulman; S Bonner-Weir; M F White
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

8.  Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.

Authors:  P Gual; V Baron; V Lequoy; E Van Obberghen
Journal:  Endocrinology       Date:  1998-03       Impact factor: 4.736

Review 9.  Signal transduction mechanism of insulin and insulin-like growth factor-1.

Authors:  T Kadowaki; K Tobe; R Honda-Yamamoto; H Tamemoto; Y Kaburagi; K Momomura; K Ueki; Y Takahashi; T Yamauchi; Y Akanuma; Y Yazaki
Journal:  Endocr J       Date:  1996-10       Impact factor: 2.349

10.  Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase.

Authors:  T Yamauchi; Y Kaburagi; K Ueki; Y Tsuji; G R Stark; I M Kerr; T Tsushima; Y Akanuma; I Komuro; K Tobe; Y Yazaki; T Kadowaki
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

View more
  19 in total

1.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

2.  Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.

Authors:  Xianyang Zhang; Tengjiao Cui; Jinlin He; Haibo Wang; Renzhi Cai; Petra Popovics; Irving Vidaurre; Wei Sha; Janine Schmid; Barbara Ludwig; Norman L Block; Stefan R Bornstein; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-16       Impact factor: 11.205

Review 3.  Diabetes mellitus--advances and challenges in human β-cell proliferation.

Authors:  Peng Wang; Nathalie M Fiaschi-Taesch; Rupangi C Vasavada; Donald K Scott; Adolfo García-Ocaña; Andrew F Stewart
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells.

Authors:  Fanxin Ma; Zhe Wei; Chunwei Shi; Yan Gan; Jia Lu; Stuart J Frank; James Balducci; Yao Huang
Journal:  Mol Endocrinol       Date:  2011-10-27

Review 5.  Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.

Authors:  Zhuo Fu; Elizabeth R Gilbert; Dongmin Liu
Journal:  Curr Diabetes Rev       Date:  2013-01-01

6.  The redundant role of JAK2 in regulating pancreatic β-cell mass.

Authors:  Diana Choi; Erica P Cai; Minna Woo
Journal:  Islets       Date:  2011 Nov-Dec       Impact factor: 2.694

7.  Glucose infusion in mice: a new model to induce beta-cell replication.

Authors:  Laura C Alonso; Takuya Yokoe; Pili Zhang; Donald K Scott; Seung K Kim; Christopher P O'Donnell; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2007-03-30       Impact factor: 9.461

Review 8.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

9.  Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor.

Authors:  Rachel E Stamateris; Rohit B Sharma; Yahui Kong; Pantea Ebrahimpour; Deepika Panday; Pavana Ranganath; Baobo Zou; Helena Levitt; Nisha Abraham Parambil; Christopher P O'Donnell; Adolfo García-Ocaña; Laura C Alonso
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

10.  Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.

Authors:  Ernesto Bernal-Mizrachi; Szabolcs Fatrai; James D Johnson; Mitsuru Ohsugi; Kenichi Otani; Zhiqiang Han; Kenneth S Polonsky; M Alan Permutt
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.